676 related articles for article (PubMed ID: 20981528)
41. Historical overview of chemical library design.
Dolle RE
Methods Mol Biol; 2011; 685():3-25. PubMed ID: 20981516
[TBL] [Abstract][Full Text] [Related]
42. Nonlinear dimensionality reduction and mapping of compound libraries for drug discovery.
Reutlinger M; Schneider G
J Mol Graph Model; 2012 Apr; 34():108-17. PubMed ID: 22326864
[TBL] [Abstract][Full Text] [Related]
43. Synergism of virtual screening and medicinal chemistry: identification and optimization of allosteric antagonists of metabotropic glutamate receptor 1.
Noeske T; Trifanova D; Kauss V; Renner S; Parsons CG; Schneider G; Weil T
Bioorg Med Chem; 2009 Aug; 17(15):5708-15. PubMed ID: 19574055
[TBL] [Abstract][Full Text] [Related]
44. Data mining a small molecule drug screening representative subset from NIH PubChem.
Xie XQ; Chen JZ
J Chem Inf Model; 2008 Mar; 48(3):465-75. PubMed ID: 18302356
[TBL] [Abstract][Full Text] [Related]
45. BEAR, a novel virtual screening methodology for drug discovery.
Degliesposti G; Portioli C; Parenti MD; Rastelli G
J Biomol Screen; 2011 Jan; 16(1):129-33. PubMed ID: 21084717
[TBL] [Abstract][Full Text] [Related]
46. Efficient substructure searching of large chemical libraries: the ABCD chemical cartridge.
Agrafiotis DK; Lobanov VS; Shemanarev M; Rassokhin DN; Izrailev S; Jaeger EP; Alex S; Farnum M
J Chem Inf Model; 2011 Dec; 51(12):3113-30. PubMed ID: 22035187
[TBL] [Abstract][Full Text] [Related]
47. Beyond the virtual screening paradigm: structure-based searching for new lead compounds.
Schlosser J; Rarey M
J Chem Inf Model; 2009 Apr; 49(4):800-9. PubMed ID: 19354328
[TBL] [Abstract][Full Text] [Related]
48. Making "real" molecules in virtual space.
Pirok G; Maté N; Varga J; Szegezdi J; Vargyas M; Dórant S; Csizmadia F
J Chem Inf Model; 2006; 46(2):563-8. PubMed ID: 16562984
[TBL] [Abstract][Full Text] [Related]
49. Flexible alignment of small molecules using the penalty method.
Shin W; Hyun SA; Chae CH; Chon JK
J Chem Inf Model; 2009 Aug; 49(8):1879-88. PubMed ID: 19645428
[TBL] [Abstract][Full Text] [Related]
50. LoFT: similarity-driven multiobjective focused library design.
Fischer JR; Lessel U; Rarey M
J Chem Inf Model; 2010 Jan; 50(1):1-21. PubMed ID: 20020715
[TBL] [Abstract][Full Text] [Related]
51. Normalizing molecular docking rankings using virtually generated decoys.
Wallach I; Jaitly N; Nguyen K; Schapira M; Lilien R
J Chem Inf Model; 2011 Aug; 51(8):1817-30. PubMed ID: 21699246
[TBL] [Abstract][Full Text] [Related]
52. Virtual screening data fusion using both structure- and ligand-based methods.
Svensson F; Karlén A; Sköld C
J Chem Inf Model; 2012 Jan; 52(1):225-32. PubMed ID: 22148635
[TBL] [Abstract][Full Text] [Related]
53. Comparative evaluation of 3D virtual ligand screening methods: impact of the molecular alignment on enrichment.
Giganti D; Guillemain H; Spadoni JL; Nilges M; Zagury JF; Montes M
J Chem Inf Model; 2010 Jun; 50(6):992-1004. PubMed ID: 20527883
[TBL] [Abstract][Full Text] [Related]
54. Recore: a fast and versatile method for scaffold hopping based on small molecule crystal structure conformations.
Maass P; Schulz-Gasch T; Stahl M; Rarey M
J Chem Inf Model; 2007; 47(2):390-9. PubMed ID: 17305328
[TBL] [Abstract][Full Text] [Related]
55. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
[TBL] [Abstract][Full Text] [Related]
56. Developing a drug-like natural product library.
Quinn RJ; Carroll AR; Pham NB; Baron P; Palframan ME; Suraweera L; Pierens GK; Muresan S
J Nat Prod; 2008 Mar; 71(3):464-8. PubMed ID: 18257534
[TBL] [Abstract][Full Text] [Related]
57. Molecular similarity concepts and search calculations.
Auer J; Bajorath J
Methods Mol Biol; 2008; 453():327-47. PubMed ID: 18712312
[TBL] [Abstract][Full Text] [Related]
58. Identification of lead compounds as antagonists of protein Bcl-xL with a diversity-oriented multidisciplinary approach.
Di Micco S; Vitale R; Pellecchia M; Rega MF; Riva R; Basso A; Bifulco G
J Med Chem; 2009 Dec; 52(23):7856-67. PubMed ID: 19852471
[TBL] [Abstract][Full Text] [Related]
59. Concept of combinatorial de novo design of drug-like molecules by particle swarm optimization.
Hartenfeller M; Proschak E; Schüller A; Schneider G
Chem Biol Drug Des; 2008 Jul; 72(1):16-26. PubMed ID: 18564216
[TBL] [Abstract][Full Text] [Related]
60. MED-3DMC: a new tool to generate 3D conformation ensembles of small molecules with a Monte Carlo sampling of the conformational space.
Sperandio O; Souaille M; Delfaud F; Miteva MA; Villoutreix BO
Eur J Med Chem; 2009 Apr; 44(4):1405-9. PubMed ID: 19022539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
